{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:43:14Z","timestamp":1786293794912,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130016, 82570511, 82270260, 82170257"],"award-info":[{"award-number":["82130016, 82570511, 82270260, 82170257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1104503"],"award-info":[{"award-number":["2022YFA1104503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2026ZD0554402"],"award-info":[{"award-number":["2026ZD0554402"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05325-8","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:25:38Z","timestamp":1786292738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incident chronic kidney disease risk and the predictive value of the uric acid-to-HDL ratio in lean and non-lean MASLD: a prospective cohort and multi-omics study"],"prefix":"10.1007","author":[{"given":"Yuting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktybek","family":"Kojonazarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-1833","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"issue":"6","key":"5325_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79(6):1542\u20131556. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"5325_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156549","author":"T Duo","year":"2026","unstructured":"Duo T, Wen Y, Bian Y et al (2026) Rising burden of MASLD and CKM syndrome in Asia: a decade of trends and future projections. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2026.156549","journal-title":"Metabolism"},{"issue":"5","key":"5325_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrneph.2017.16","volume":"13","author":"G Targher","year":"2017","unstructured":"Targher G, Byrne CD (2017) Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol 13(5):297\u2013310. https:\/\/doi.org\/10.1038\/nrneph.2017.16","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"5325_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, Targher G (2026) Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA 335(2):163\u2013174. https:\/\/doi.org\/10.1001\/jama.2025.19615","journal-title":"JAMA"},{"issue":"3","key":"5325_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO","year":"2024","unstructured":"EASL-EASD-EASO (2024) Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol."},{"issue":"4","key":"5325_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gutjnl-2025-336127","volume":"75","author":"Z Huo","year":"2026","unstructured":"Huo Z, Chen Y, Huang Y et al (2026) Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts. Gut 75(4):772\u2013785. https:\/\/doi.org\/10.1136\/gutjnl-2025-336127","journal-title":"Gut"},{"issue":"6","key":"5325_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102569","volume":"49","author":"N Nso","year":"2024","unstructured":"Nso N, Mergen D, Ikram M et al (2024) Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: a comprehensive meta-analysis. Curr Probl Cardiol 49(6):102569. https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102569","journal-title":"Curr Probl Cardiol"},{"key":"5325_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914651","author":"F Carli","year":"2023","unstructured":"Carli F, Sabatini S, Gaggini M, Sironi AM, Bedogni G, Gastaldelli A (2023) Fatty liver index (FLI) identifies not only individuals with liver steatosis but also at high cardiometabolic risk. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914651","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5325_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779","journal-title":"PLoS Med"},{"issue":"1","key":"5325_CR10","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/s41467-020-15948-9","volume":"11","author":"TJ Littlejohns","year":"2020","unstructured":"Littlejohns TJ, Holliday J, Gibson LM et al (2020) The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat Commun. 11(1):2624. https:\/\/doi.org\/10.1038\/s41467-020-15948-9","journal-title":"Nat Commun."},{"key":"5325_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70851","author":"H Zhang","year":"2026","unstructured":"Zhang H, Hu Y, Cai J et al (2026) Fatty liver index as an upstream marker of glycaemic and cardiometabolic dysregulation preceding MASLD: evidence from two longitudinal cohorts. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.70851","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"5325_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/oby.23687","volume":"31","author":"L Gnatiuc Friedrichs","year":"2023","unstructured":"Gnatiuc Friedrichs L, Trichia E, Aguilar-Ramirez D, Preiss D (2023) Metabolic profiling of MRI-measured liver fat in the UK Biobank. Obesity (Silver Spring) 31(4):1121\u20131132. https:\/\/doi.org\/10.1002\/oby.23687","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"5325_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3967\/bes2022.111","volume":"36","author":"H Zhao","year":"2023","unstructured":"Zhao H, Qiu X, Li HZ, Cui JJ, Sun YY (2023) Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease risk among Chinese adults. Biomed Environ Sci 36(1):1\u20139. https:\/\/doi.org\/10.3967\/bes2022.111","journal-title":"Biomed Environ Sci"},{"key":"5325_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1417485","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Liu Q, Yao Z (2024) The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study. Front Endocrinol (Lausanne) 15:1417485. https:\/\/doi.org\/10.3389\/fendo.2024.1417485","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5325_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK (2019) The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev 40(5):1367\u20131393. https:\/\/doi.org\/10.1210\/er.2019-00034","journal-title":"Endocr Rev"},{"issue":"11","key":"5325_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/circresaha.125.325602","volume":"136","author":"CJM Lee","year":"2025","unstructured":"Lee CJM, Kosyakovsky LB, Khan MS et al (2025) Cardiovascular, kidney, liver, and metabolic interactions in heart failure: breaking down silos. Circ Res 136(11):1170\u20131207. https:\/\/doi.org\/10.1161\/circresaha.125.325602","journal-title":"Circ Res"},{"issue":"4","key":"5325_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/13813455.2020.1745851","volume":"128","author":"N Sharma","year":"2022","unstructured":"Sharma N, Sircar A, Anders HJ, Gaikwad AB (2022) Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches. Arch Physiol Biochem 128(4):1024\u20131038. https:\/\/doi.org\/10.1080\/13813455.2020.1745851","journal-title":"Arch Physiol Biochem"},{"issue":"5","key":"5325_CR18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(5):1264-1281.e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","journal-title":"Gastroenterology"},{"key":"5325_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230x-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L et al (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33. https:\/\/doi.org\/10.1186\/1471-230x-6-33","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"5325_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"issue":"4","key":"5325_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG (2015) Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol 181(4):251\u2013260. https:\/\/doi.org\/10.1093\/aje\/kwu283","journal-title":"Am J Epidemiol"},{"issue":"7982","key":"5325_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"issue":"6973","key":"5325_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6973.170","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310(6973):170. https:\/\/doi.org\/10.1136\/bmj.310.6973.170","journal-title":"BMJ"},{"issue":"31","key":"5325_CR24","doi-asserted-by":"publisher","first-page":"2abh2169","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, M\u00e9ar L et al (2021) A single-cell type transcriptomics map of human tissues. Sci Adv. 7(31):2abh2169. https:\/\/doi.org\/10.1126\/sciadv.abh2169","journal-title":"Sci Adv."},{"issue":"6509","key":"5325_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx Consortium","year":"2020","unstructured":"The GTEx Consortium (2020) The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 369(6509):1318\u20131330. https:\/\/doi.org\/10.1126\/science.aaz1776","journal-title":"Science."},{"issue":"1","key":"5325_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41597-019-0351-8","volume":"7","author":"J Liao","year":"2020","unstructured":"Liao J, Yu Z, Chen Y et al (2020) Single-cell RNA sequencing of human kidney. Sci Data. 7(1):4. https:\/\/doi.org\/10.1038\/s41597-019-0351-8","journal-title":"Sci Data."},{"issue":"8015","key":"5325_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","volume":"630","author":"C Gribben","year":"2024","unstructured":"Gribben C, Galanakis V, Calderwood A et al (2024) Acquisition of epithelial plasticity in human chronic liver disease. Nature 630(8015):166\u2013173. https:\/\/doi.org\/10.1038\/s41586-024-07465-2","journal-title":"Nature"},{"issue":"4","key":"5325_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16159","volume":"45","author":"J Bilson","year":"2025","unstructured":"Bilson J, Hydes TJ, McDonnell D et al (2025) Impact of metabolic syndrome traits on kidney disease risk in individuals with MASLD: a UK biobank study. Liver Int 45(4):e16159. https:\/\/doi.org\/10.1111\/liv.16159","journal-title":"Liver Int"},{"issue":"3","key":"5325_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/biomedicines10030720","volume":"10","author":"F Baratta","year":"2022","unstructured":"Baratta F, D\u2019Erasmo L, Di Costanzo A et al (2022) Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease. Biomedicines. 10(3):720. https:\/\/doi.org\/10.3390\/biomedicines10030720","journal-title":"Biomedicines."},{"issue":"20","key":"5325_CR30","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL et al (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/cir.0000000000001184","journal-title":"Circulation"},{"issue":"1","key":"5325_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP (2023) The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol 22(1):195. https:\/\/doi.org\/10.1186\/s12933-023-01937-x","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5325_CR32","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00499.2025","volume":"330","author":"S Gunnarsson","year":"2026","unstructured":"Gunnarsson S, Vito O, Unwin RJ (2026) Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management. Am J Physiol Cell Physiol 330(1):C1-c8. https:\/\/doi.org\/10.1152\/ajpcell.00499.2025","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"5325_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/dmrr.315","volume":"18","author":"P Arnaud","year":"2002","unstructured":"Arnaud P, Kalabay L (2002) Alpha2-HS glycoprotein: a protein in search of a function. Diabetes Metab Res Rev 18(4):311\u2013314. https:\/\/doi.org\/10.1002\/dmrr.315","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"5325_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/eje-17-1053","volume":"178","author":"C Sujana","year":"2018","unstructured":"Sujana C, Huth C, Zierer A et al (2018) Association of fetuin-A with incident type 2 diabetes: results from the MONICA\/KORA Augsburg study and a systematic meta-analysis. Eur J Endocrinol 178(4):389\u2013398. https:\/\/doi.org\/10.1530\/eje-17-1053","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"5325_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01439-8","volume":"21","author":"A Birukov","year":"2022","unstructured":"Birukov A, Polemiti E, J\u00e4ger S, Stefan N, Schulze MB (2022) Fetuin-A and risk of diabetes-related vascular complications: a prospective study. Cardiovasc Diabetol 21(1):6. https:\/\/doi.org\/10.1186\/s12933-021-01439-8","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"5325_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10787-021-00837-4","volume":"29","author":"O Sardana","year":"2021","unstructured":"Sardana O, Goyal R, Bedi O (2021) Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. Inflammopharmacology 29(4):1061\u20131074. https:\/\/doi.org\/10.1007\/s10787-021-00837-4","journal-title":"Inflammopharmacology"},{"issue":"2","key":"5325_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","volume":"132","author":"H Loghmani","year":"2018","unstructured":"Loghmani H, Conway EM (2018) Exploring traditional and nontraditional roles for thrombomodulin. Blood 132(2):148\u2013158. https:\/\/doi.org\/10.1182\/blood-2017-12-768994","journal-title":"Blood"},{"key":"5325_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020249","author":"A Tripodi","year":"2022","unstructured":"Tripodi A, Lombardi R, Primignani M, La Mura V, Peyvandi F, Fracanzani AL (2022) Hypercoagulability in patients with non-alcoholic fatty liver disease (NAFLD): causes and consequences. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10020249","journal-title":"Biomedicines"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05325-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05325-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05325-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:25:43Z","timestamp":1786292743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05325-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":38,"alternative-id":["5325"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05325-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]},"assertion":[{"value":"21 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report there are no competing interests to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Biobank received ethical approval from the North West Multi-centre Research Ethics Committee, and all participants provided written informed consent. This study was conducted in accordance with the Declaration of Helsinki. This research was conducted under application number 656613.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}